Myasthenia Gravis (MG), an autoimmune disorder that postsynaptic nicotinic receptors are targeted, is characterized by muscle weakness worsening with fatigue and improving partially or completely with anticholinesterase drugs. In this report, we aimed to present a 31-year-old pregnant case whom Myastenia Gravis was diagnosed 7 years before. The patient was admitted to the neurology clinic with respiratory distress, bilateral ptosis, fatigue and diplopia. She was hospitalized since her complaints had worsened after her intentional cessation of the treatment at the tenth gestational week. Pyridostigmine and corticosteroid treatment were initiated. After recovering of the symptoms, the patient was transferred to the obstetrics and gynecology department for delivery when labor started. She delivered vaginally at 39th weeks of gestation. No maternal or neonatal complications occurred and the patient was discharged on the third day postpartum.In conclusion, although MG may be sometimes a mortal disease, it is likely for a patient suffering with MG to have a normal gestation and normal spantaneous delivery with multidisciplinar management.
Alan : Sağlık Bilimleri
Dergi Türü : Ulusal
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|